1 / 26

1 st International Treatment as Prevention (TasP) Workshop Overview

British Columbia Centre for Excellence in HIV/AIDS . 1 st International Treatment as Prevention (TasP) Workshop Overview. Julio Montaner MD, DSc( hon ), FRCPC, FCCP, FRSC, OBC Director, BC-Centre for Excellence on HIV/AIDS, Providence Health Care

ann
Télécharger la présentation

1 st International Treatment as Prevention (TasP) Workshop Overview

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. British Columbia Centre for Excellence in HIV/AIDS 1st International Treatment as Prevention (TasP) Workshop Overview Julio Montaner MD, DSc(hon), FRCPC, FCCP, FRSC, OBC Director, BC-Centre for Excellence on HIV/AIDS, Providence Health Care Professor of Medicine and Head, Division of AIDS, University of British Columbia Past-President, International AIDS Society

  2. British Columbia Centre for Excellence in HIV/AIDS Additional Industry Support:

  3. Treatment as PreventionvsARV Chemoprophylaxis

  4. Integrating HIV prevention and treatment: From slogans to impact Sub Saharan Africa Salomon JA, Hogan DR, Stover J, Stanecki KA, Walker N, et al. (2005). PLoS Med 2(1): e16

  5. Treatment as PreventionHeterosexual Couples

  6. HIV Incidence 2.24 (1.84-2.72) 92% Reduction HIV Incidence (per 100-person-years) 0.37 (0.09-2.04) No Yes HIV Partner Had Started HAART Donnell D, et al. Lancet. 2010;375:2092-2098

  7. HPTN 052 (www.hptn.org) • HR = 0.37 or 96.3% reduction in transmission • No difference whether index pt was M or F % Deferred Immediate M Cohen et al, NIH Press Conference May 12th 2011. To be presented at IAS-Rome, July 2011

  8. HPTN 052 (www.hptn.org) Extra-Pulmonary TB Deferred : 17 cases Immediate : 3 cases 84% Reduction % Deferred Immediate M Cohen et al, NIH Press Conference May 12th 2011. To be presented at IAS-Rome, July 2011

  9. Treatment as PreventionMSM

  10. Determinants of HIV-1 Transmission in MSM: A Combined Clinical, Epidemiological and Phylogenetic Approach

  11. Treatment as PreventionIDUs

  12. Wood et al, BMJ, 2009 Whiskers represent 95% confidence intervals.

  13. Wood et al, BMJ, 2009 Whiskers represent 95% confidence intervals.

  14. HAART Reduces HIV incidence in IDUs % Injecting % on HAART Community pVL HIV Incidence G Kirk, …, D Vlahov for the Alive Cohort, CROI 2011

  15. HAART Reduces HIV incidence in IDUs • From 1997, HIV incidence decreased by 74% (IRR 0.26, 0.08-0.81) for each log decline in community pVL • In a separate model, HIV incidence decreased by 5% (3-8%) for each 1% increase in the proportion of HAART treated patients • For the entire follow up period, for each 1% decline in the proportion of HIV+ patients actively injecting, there was a 3% decline in HIV incidence. - However, this effect was largely restricted to the pre-HAART era G Kirk, …, D Vlahov for the Alive Cohort, CROI 2011

  16. Tuesday Feb 8th 2011

  17. Treatment as PreventionPopulation Based Studies

  18. Community Viral Load and New HIV Cases in SFco n=12,512 unduplicated HIV-positive individuals. Das M, Chu PL, Santos G-M, Scheer S, Vittinghoff E, et al. Decreases in Community Viral Load Are Accompanied by Reductions in New HIV Infections in San Francisco. PLoS ONE 2010 5(6): e11068. doi:10.1371/journal.pone.0011068

  19. Treatment as PreventionNext Steps

  20. Spectrum of Engagement in HIV Care - USA The authors estimated that only about 19% of HIV infected individuals in the USA have an undetectable HIV-1 RNA level Gardner E, McLees M, Steiner J, del Rio C, Burman W, Clin Infect Dis. (2011) 52 (6): 793-800

  21. Spectrum of Engagement in HIV Care - USA Gardner E, McLees M, Steiner J, del Rio C, Burman W, Clin Infect Dis. (2011) 52 (6): 793-800

  22. Montaner J, The Lancet, Vol 378: July 16th 2011, pages 208-209

More Related